Ilse S. Pienaar

2.0k total citations · 1 hit paper
46 papers, 1.5k citations indexed

About

Ilse S. Pienaar is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Ilse S. Pienaar has authored 46 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Neurology, 21 papers in Cellular and Molecular Neuroscience and 20 papers in Molecular Biology. Recurrent topics in Ilse S. Pienaar's work include Parkinson's Disease Mechanisms and Treatments (20 papers), Mitochondrial Function and Pathology (13 papers) and Neurological disorders and treatments (13 papers). Ilse S. Pienaar is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (20 papers), Mitochondrial Function and Pathology (13 papers) and Neurological disorders and treatments (13 papers). Ilse S. Pienaar collaborates with scholars based in United Kingdom, South Africa and United States. Ilse S. Pienaar's co-authors include Glenda E. Gillies, Zahi Qamhawi, Joanna L. Elson, David T. Dexter, Jürgen Götz, Sarah Threlfell, Stephanie J. Cragg, Richard Exley, Michael A. Clements and Jürgen Wess and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and Biomaterials.

In The Last Decade

Ilse S. Pienaar

46 papers receiving 1.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sex differences in Parkinson’s disease

2014 359 citations Glenda E. Gillies, Ilse S. Pienaar et al. Frontiers in Neuroendocrinology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ilse S. Pienaar United Kingdom	22	618	616	559	196	173	46	1.5k
Cristina Januário Portugal	23	485 0.8×	717 1.2×	570 1.0×	246 1.3×	257 1.5×	70	1.5k
Michael F. Salvatore United States	24	1.1k 1.8×	699 1.1×	439 0.8×	168 0.9×	213 1.2×	58	1.7k
Andréas Moser Germany	22	600 1.0×	411 0.7×	317 0.6×	118 0.6×	171 1.0×	94	1.3k
Ezia Guatteo Italy	28	1.1k 1.7×	477 0.8×	822 1.5×	238 1.2×	231 1.3×	58	1.9k
M. V. Ugrumov Russia	27	1.0k 1.7×	480 0.8×	449 0.8×	106 0.5×	317 1.8×	161	2.2k
Karsten M. Strauss Germany	6	560 0.9×	413 0.7×	448 0.8×	153 0.8×	164 0.9×	7	1.1k
Michela Tantucci Italy	24	824 1.3×	413 0.7×	489 0.9×	409 2.1×	302 1.7×	46	1.8k
Amanda Smith United States	21	642 1.0×	466 0.8×	389 0.7×	283 1.4×	228 1.3×	32	1.6k
Albert C. Ludolph Germany	17	634 1.0×	780 1.3×	538 1.0×	199 1.0×	232 1.3×	23	1.4k
Yumei Wang China	22	981 1.6×	262 0.4×	1.1k 2.0×	239 1.2×	154 0.9×	39	1.8k

Countries citing papers authored by Ilse S. Pienaar

Since Specialization

Citations

This map shows the geographic impact of Ilse S. Pienaar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilse S. Pienaar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilse S. Pienaar more than expected).

Fields of papers citing papers by Ilse S. Pienaar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilse S. Pienaar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilse S. Pienaar. The network helps show where Ilse S. Pienaar may publish in the future.

Co-authorship network of co-authors of Ilse S. Pienaar

This figure shows the co-authorship network connecting the top 25 collaborators of Ilse S. Pienaar. A scholar is included among the top collaborators of Ilse S. Pienaar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilse S. Pienaar. Ilse S. Pienaar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pfaff, Abigail L., Ilse S. Pienaar, Sulev Kõks, et al.. (2022). Mitochondrial DNA variation in Parkinson’s disease: Analysis of “out-of-place” population variants as a risk factor. Frontiers in Aging Neuroscience. 14. 921412–921412. 12 indexed citations

Pienaar, Ilse S., et al.. (2021). Investigation of the correlation between mildly deleterious mtDNA Variations and the clinical progression of multiple sclerosis. Multiple Sclerosis and Related Disorders. 53. 103055–103055. 3 indexed citations

Chudasama, Yogita, et al.. (2020). Dissociable contributions of mediodorsal and anterior thalamic nuclei in visual attentional performance: A comparison using nicotinic and muscarinic cholinergic receptor antagonists. Journal of Psychopharmacology. 34(12). 1371–1381. 3 indexed citations

Sharma, Puneet, Lisa Wells, Gaia Rizzo, et al.. (2020). DREADD Activation of Pedunculopontine Cholinergic Neurons Reverses Motor Deficits and Restores Striatal Dopamine Signaling in Parkinsonian Rats. Neurotherapeutics. 17(3). 1120–1141. 21 indexed citations

Lewis, Frank W., Joanna L. Elson, Véronique Hubscher‐Bruder, et al.. (2020). Novel 1-hydroxypyridin-2-one metal chelators prevent and rescue ubiquitin proteasomal-related neuronal injury in an in vitro model of Parkinson’s disease. Archives of Toxicology. 94(3). 813–831. 8 indexed citations

Pienaar, Ilse S., et al.. (2019). The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects. Neurochemistry International. 129. 104495–104495. 26 indexed citations

Tomas, Cara, Ilse S. Pienaar, Victoria Strassheim, et al.. (2019). MtDNA population variation in Myalgic encephalomyelitis/Chronic fatigue syndrome in two populations: a study of mildly deleterious variants. Scientific Reports. 9(1). 2914–2914. 22 indexed citations

Elson, Joanna L., et al.. (2017). Temporal-Spatial Profiling of Pedunculopontine Galanin-Cholinergic Neurons in the Lactacystin Rat Model of Parkinson’s Disease. Neurotoxicity Research. 34(1). 16–31. 6 indexed citations

McArthur, Simon, et al.. (2015). Sex-specific disruption of murine midbrain astrocytic and dopaminergic developmental trajectories following antenatal GC treatment. Brain Structure and Function. 221(5). 2459–2475. 11 indexed citations

10.

Pienaar, Ilse S., Sarah E. Gartside, Puneet Sharma, et al.. (2015). Pharmacogenetic stimulation of cholinergic pedunculopontine neurons reverses motor deficits in a rat model of Parkinson’s disease. Molecular Neurodegeneration. 10(1). 47–47. 45 indexed citations

11.

Elson, Joanna L., Abi G. Yates, & Ilse S. Pienaar. (2015). Pedunculopontine cell loss and protein aggregation direct microglia activation in parkinsonian rats. Brain Structure and Function. 221(4). 2319–2341. 19 indexed citations

12.

Gillies, Glenda E., et al.. (2014). Sex differences in Parkinson’s disease. Frontiers in Neuroendocrinology. 35(3). 370–384. 359 indexed citations breakdown →

13.

Pienaar, Ilse S., Heyne Lee, Joanna L. Elson, et al.. (2014). Deep-brain stimulation associates with improved microvascular integrity in the subthalamic nucleus in Parkinson's disease. Neurobiology of Disease. 74. 392–405. 93 indexed citations

14.

Sharma, Puneet & Ilse S. Pienaar. (2014). Pharmacogenetic and optical dissection for mechanistic understanding of Parkinson's disease: Potential utilities revealed through behavioural assessment. Neuroscience & Biobehavioral Reviews. 47. 87–100. 9 indexed citations

15.

Pienaar, Ilse S., et al.. (2013). Behavioral testing regimens in genetic-based animal models of Parkinson's disease: Cogencies and caveats. Neuroscience & Biobehavioral Reviews. 37(5). 846–859. 9 indexed citations

16.

Pienaar, Ilse S. & Patrick F. Chinnery. (2012). Existing and emerging mitochondrial-targeting therapies for altering Parkinson's disease severity and progression. Pharmacology & Therapeutics. 137(1). 1–21. 11 indexed citations

17.

Lax, Nichola Z., Ilse S. Pienaar, Amy K. Reeve, et al.. (2012). Microangiopathy in the cerebellum of patients with mitochondrial DNA disease. Brain. 135(6). 1736–1750. 37 indexed citations

18.

Pienaar, Ilse S., David J. Burn, Christopher M. Morris, & David T. Dexter. (2011). Synaptic Protein Alterations in Parkinson’s Disease. Molecular Neurobiology. 45(1). 126–143. 26 indexed citations

19.

Threlfell, Sarah, Michael A. Clements, Ilse S. Pienaar, et al.. (2010). Striatal Muscarinic Receptors Promote Activity Dependence of Dopamine Transmission via Distinct Receptor Subtypes on Cholinergic Interneurons in Ventral versus Dorsal Striatum. Journal of Neuroscience. 30(9). 3398–3408. 165 indexed citations

20.

Pienaar, Ilse S., Lauriston Kellaway, Vivienne A. Russell, et al.. (2008). Maternal separation exaggerates the toxic effects of 6-hydroxydopamine in rats: Implications for neurodegenerative disorders. Stress. 11(6). 448–456. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact